2m 2m 2m 2m 2m 2m 2m
NovelStem Intl (NSTM)
OTC
$0.01+$0.003 (+24.55%)
Price as of May 26, 2026- $675,854.00Market Cap
- -59.56%1-Year Change
- Diagnostics & ResearchIndustry
NovelStem Intl (NSTM)
$0.01+$0.003 (+24.55%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.01
$0.01
$0.01
1-Year Range
$0.009
$0.03
$0.01
Latest Close$0.01
Change
+$0.003 (+19.71%)
Volume300
Market Cap$675,854.00
Shares Outstanding49.3M
P/E (TTM)-4.89
Diluted EPS (TTM)-$0.003
Enterprise Value$3.1M
Information as of 05/26/2026
Company Profile
NovelStem International Corp.
https://www.novelstem.com$675,854.00
Market Cap
-$132,469.00
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
2255 Glades Road, Boca Raton, FL, United States, 33431
410 598 9024NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
Key Executives
- Christine Jenkins
- David Collins
- Jan H. Loeb
- Mitchell Rubenstein
Current Ownership Distribution
- Other49.3M (99.95%)
- Institutions25,000 (0.05%)
- Mutual Funds0 (0.00%)
- Insiders0 (0.00%)